healthscene - Tumblr blog

[healthscene]

How Cloud Computing is Transforming the Healthcare Industry Dynamics?

What is Cloud Computing in Healthcare Industry?

The use of cloud computing in the healthcare industry has evolved rapidly and has touched new heights. Over the past two years in the pandemic, Covid 19 has changed the overall healthcare structure. Organizations across different healthcare sectors are adopting cloud computing as a reliable source of precise data and healthcare delivery, making the services more efficient and quick among the general public. The efficiency of cloud computing has bought up satisfaction among various stakeholders, patients, and medical staff.

Over the past years, due to the increasing population and the prevalence of new diseases, there has been an immense growth in the healthcare industry's demand. There was an urgent need for a skillful solution that Xcan pass the real-time patient data across the different fields, so the use of cloud computing came in working and the organizations found it reliable to use. Several tech giants and startups and showing interest in building and providing a cloud computing service in the healthcare domain to cater their needs.

Cloud computing requires little to no management from the user's end and refers to the on-demand availability of the resources through the use of data servers, databases, networking, and software. The data is available to multiple users at multiple locations and is accessible over the internet from different central data servers.

Key Applications of Cloud Technology in Healthcare Industry

Cloud Technology and Healthcare Data Protection 

With the use of Cloud Computing in healthcare, it becomes easier for the organization to maintain the patient’s medical history such as overall health history, problems, medications, etc. Companies are focusing on maintaining the electronic healthcare records of the customers as it becomes easier for anyone to access the data anytime and improve the efficiency and effectiveness of the organization.

Teamwork Through Cloud Computing

Cloud Computing technologies provide a unified platform that can be used or accessed at multiple points from mobile, tablets, and desktops. It makes the communication and sharing of data easier within the organization. It also helps in improving the effectiveness among the people in the organization may it be a nurse, doctors, medical students, or scribing program.

Cloud-based Systems for Clinical Data Exchange

The effective use of Cloud-based systems can be seen in - Real-time clinical data exchange across the healthcare systems, commercial labs, health projects, and other channel partners. In today’s scenario, several companies are working dedicatedly to provide clinical data exchange platforms with more accuracy and consistency. The demand for Cloud-based systems for clinical data exchange is expected to grow in the future with the steady use of cloud computing in healthcare.

Benefits of Cloud Computing in Healthcare

With the on-demand availability, internet-based services, and high data availability among the different servers,  and all of its benefits to successfully handle the demands of patients and business, Tech-savvy healthcare professionals are turning to cloud computing.

Key Players in the Healthcare Cloud Computing 

There are many tech giants and startups which are continuously offering cloud computing services in the healthcare industry. Some of the companies manufacturing products in teh market include - Allscripts Healthcare Solutions, Amazon Web Services, Ambra Health, Athenahealth, CareCloud, Carestream Health, Cerner Corporation, Cisco, ClearData Networks, Dell, Inc, DICOM Grid, eClinicalWorks, EMC, Epic Systems Corporation, GNAX Health, IBM, INFINITT Healthcare, and several others. 

Future of Cloud Computing in healthcare

Due to the growing pressure and demand in the healthcare systems, the Cloud computing market in healthcare is expected to observe phenomenal growth in the future. With the rising prevalence of chronic diseases and the aging population, the use of cloud computing provides a sustainable solution for data storage. Moreover, the rising awareness about the digital tools and techniques, big data, and telemedicine technologies, will impact the overall growth of cloud computing in healthcare.

To know more about our Competitive Services, Click here: Pharma Competitive Intelligence

Cloud computing, Cloud computing services, Cloud computing companies, Healthcare cloud computing market, Cloud computing in healthcare, Healthcare cloud computing, Cloud computing healthcare, Benefits of cloud computing in healthcare, Cloud computing in healthcare industry, Advantages of cloud computing in healthcare, Future of cloud computing in healthcare, Cloud computing for healthcare, Challenges of cloud computing in healthcare, cloud computing applications,

[healthscene]

What is Driving the Post Traumatic Stress Disorder (PTSD) Treatment Market?

What is Post Traumatic Stress Disorder (PTSD)?

Post-Traumatic Stress Disorder (PTSD) is defined as the complex cognitive, emotional, and behavioral consequences that are caused due to psychological trauma. In Post-Traumatic Stress Disorder, the person suffers from intrusive thoughts, nightmares, flashbacks, and terrifying episodes of stress and sleepless nights. 

The symptoms of Post-Traumatic Stress Disorder occur soon in a month or less after a stressful experience, although the occurrence of symptoms can be seen late after years. The symptoms that occur during the Post-Traumatic Stress Disorder cause substantial issues in society and the workplace, as well as in the personal relationships of the person. PTSD symptoms can also harm the daily routine of a person.

Post-Traumatic Stress Disorder Epidemiology Insights- 

According to the DelveInsight analysis, the prevalence of Post-Traumatic Stress Disorder is highest in the United States, affecting 3.5% of the adults in the US every year. And 1 out of 11 people is estimated to be diagnosed with PTSD in their lifetime. Moreover, Women are more prone to develop PTSD than Men. According to the DelveInsight’s Post-Traumatic Stress Disorder Epidemiology Forecast Report, the prevalence of PTSD in the 7MM affected the population of more than 13 million in the year 2021, out of which the diagnosed prevalent cases were around 5 million. 

Post-Traumatic Stress Disorder Market Insights-

The market value of Post-Traumatic Stress Disorder in the 7MM was estimated at USD 1,740.2 million in 2021, which is further estimated to grow in the future growth with a significant CAGR owing to the increase in the prevalence and rise in initiatives to create public awareness and knowledge of the disease.

Moreover, the dynamics of the PTSD treatment market are expected to change in the future due to several factors. One of the main reasons which are driving the PTSD treatment market is the introduction of novel drugs and therapeutic drugs, which will give patients hope as alternate options for PTSD treatment and will have a positive impact on the Post-Traumatic Stress Disorder market.

Key companies in the Post-Traumatic Stress Disorder market-

Several companies are working on developing therapeutic drugs, and many drugs are underlying in the Post-Traumatic Stress Disorder Pipeline. The companies are listed as-

Pfizer

Bionomics

AstraZeneca

Alto Biosciences

Sage Therapeutics

Nobilis Therapeutics

Jazz Pharmaceuticals

Tonix Pharmaceuticals

Post-Traumatic Stress Disorder Emerging Therapies-

There are several companies that are actively developing therapies for Post-Traumatic Stress Disorder. Here is a list of the promising Post-Traumatic Stress Disorder drugs in various stages of development are NYX-783, JZP150, Brexpiprazole and Zoloft Combination, BNC210, and others.

Expected Roadblocks: The Post Stress Disorder Market is growing but there there are still a few barriers that are limiting the growth of the Post Stress Disorder Market. One of the reasons is, that the heterogeneity of the symptoms and delayed onset of PTSD are acting as a barrier to the growth of the Post Traumatic Stress Disorder treatment market.

[healthscene]

The revolution in pharmaceutical companies through the influence of contract organizations

The term contract development and manufacturing organization (CDMO) refers to companies that provide comprehensive services and solutions to the pharmaceutical and biotech industries, ranging from drug development to product packaging. Clinical research and development, formulation assistance, a smooth manufacturing process, analytical and regulatory support, and efficient packaging services are just a few of the services provided by these organizations. 

The following are some of the advantages of CDMOs: 

The ability to scale from the drug discovery stage to production at a cheaper cost. 

Expertise, capability, and flexibility in the drug development process and other aspects of drug development.

Allows businesses to benefit from equipment and technology without having to own it. 

The manufacturing process can save roughly 30-35 percent of the entire expenses of medication development.

Because of the CDMOs' dependability, outsourcing partners have become more adaptable in answering specific demands, allowing them to expand their current services, research, and development departments. The pharmaceutical sector faced operational issues as a result of the pandemic, including the capacity to continue supplying needed drugs. At the same time, it created chances for the CDMO industry to play a key role in the COVID-19 therapy and vaccine development process. Pharmaceutical businesses are increasingly looking for outsourcing alternatives to assist manage complexity while decreasing time to market, costs, and risk as the pressure to develop and provide pharmaceuticals to satisfy ever-increasing worldwide demand grows.

The segmentation of pharmaceutical services is broadly categorized into three categories which are Contract Research Organizations (CROs) services that provide drug discovery and development support to pharmaceutical companies, Contract Development Manufacturing Organizations (CDMOs) services that include drug development, API production, and formulation requirements, and Contract Packaging Organizations (CPOs) services that provide end-to-end services and include primary, secondary, and tertiary packaging. 

In the development process, drug developers are collaborating with CDMOs and CROs to help overcome crucial difficulties and achieve higher efficiency across the drug development industry. According to DeleInsight, the global biologic drug substance manufacturing market was worth USD 303.95 billion in 2020 and is expected to increase at a CAGR of 9.59 percent from 2021 to 2026. Better therapeutic effects of biologics when compared to small molecules, increasing demand for biologic drugs in various indications, demand for COVID-19 vaccines, growing capital investment in biologics manufacturing, and surging interest in the development of targeted medicines in the form of gene therapy for rising cancer and rare indications are some of the major factors driving the growth of the global biologics drug substance manufacturing market.

Top CDMO companies operating in the market include Cambrex Corporation, CARBOGEN AMCIS, CordenPharma, Dipharma Francis Srl, Flamma Group, Formosa Laboratories Inc, Frontage Laboratories Inc, Fujifilm Diosynth Biotechnologies, Hovione, Jubilant Biosys Limited, Laurus Labs, Laviana Pharma Co, Ltd, LEBSA, Lonza Group AG, Neuland Laboratories Ltd, NextPharma GmbH, Northway Biotech, Novasep, Syngene International Limited, Wavelength Pharmaceuticals, and Windlas Biotech, among others.

CDMOs are adopting continuous or flexible manufacturing methods, which have several key advantages over batch manufacturing, including a 50-70% workforce reduction, a 15-30% reduction in production costs, a 50% reduction in product difference, a 40% reduction in energy usage, a 50-70% reduction in footprint requirement, and accelerated scale-up. CM minimizes API waste, production time, improves scale-up economies, enables stronger quality assurance, and adapts effectively to changes in market demand, all of which will help the market develop at a healthy rate throughout the projection period. As a result, CDMOs are proving to be extremely beneficial to the biotechnology and pharmaceutical industries, as they provide prospective capabilities and cost savings over in-house manufacturing.

DelveInsght’s Competitive Intelligence Service includes a multidimensional coverage, helping to keep track of competitors and gain traction in the dynamic market by overcoming the challenges and expediting business growth through a strategic and tactical approach.

To know more about our Consulting Services, Click here: Healthcare Consulting Services